Welcome to our dedicated page for Yijia Group SEC filings (Ticker: YJGJ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
YJGJ filings document the regulatory record of a blank-check public issuer with common stock identified on the OTC Pink Sheets. The Form 8-K reports cover the completed name change from Yijia Group Corp. to VitaNova Life Sciences Corporation, amendments to the articles of incorporation, board and majority-stockholder approvals, trading-symbol disclosures, and capital-structure matters.
VitaNova Life Sciences Corporation, formerly Yijia Group Corp., reports that its corporate name change and a reverse stock split have now been cleared for trading purposes. The Certificate of Amendment filed in Nevada on January 9, 2026 changed the name to VitaNova Life Sciences Corporation and implemented a 1‑for‑3 reverse stock split, so each stockholder receives one share for every three previously held.
FINRA has completed its review, and both the name change and reverse split take effect on the OTC Pink marketplace as of January 27, 2026. The company’s common stock will trade under the symbol YJGJD for 20 trading days beginning January 27, 2026, after which the ticker will change to VNOV. The company has also obtained a new CUSIP number, 98585W403. The company states that no action is required by current stockholders in relation to these changes.
Yijia Group Corp. is changing its corporate structure and capital setup. The company has filed a Certificate of Amendment in Nevada to change its name to VitaNova Life Sciences Corporation, with the filing effective January 9, 2026, while FINRA processes the name change. In connection with these actions, the company has obtained a new CUSIP number, 98585W403, for its common stock and plans to adopt a new ticker symbol, which it is still evaluating.
The amendment also implements a 1-for-3 reverse stock split, so each stockholder will receive one share of common stock for every three shares held. Earlier, the company increased its authorized capital to 210,000,000 shares, including 200,000,000 common shares and 10,000,000 preferred shares, and designated 3,000,000 of those preferred shares as Series A Preferred Stock with specific rights and preferences approved by the board and majority stockholders.
Yijia Group Corp reported stronger results for the quarter ended October 31, 2025, as its dietary supplement business drove growth. Revenue reached $427,115, up from $292,118, with gross profit of $260,803 and margin improving to 61%. For the first six months, revenue rose to $531,014, a 33% increase, while the net loss narrowed to $10,491 from $22,564 and operating cash flow turned into a $476,471 inflow.
The company ended the quarter with $1,259,281 in cash and total assets of $2,336,244 against $438,051 in current liabilities and no long-term debt. Results are highly concentrated, with a few U.S. customers contributing over 60% of revenue and one vendor providing all purchases, and management continues to disclose material weaknesses in internal controls due to the absence of an independent audit committee.
Yijia Group Corp. plans several major corporate changes. The company intends to change its name to VitaNova Life Sciences Corporation, with a new ticker symbol to follow on OTC Markets; until then, its common stock will continue trading under YJGJ with the current CUSIP.
The board and a majority of common shareholders have approved a reverse stock split in a ratio range of 1-for-2 to 1-for-3, meaning each shareholder would receive one new share for every two or three existing shares once the final ratio is set. They also approved an increase in authorized capital to 85,000,000 shares, consisting of 75,000,000 common and 10,000,000 preferred shares, and the creation of blank check preferred stock that the board can designate into series with different rights over time. These changes will be implemented by filing a Certificate of Amendment with the Nevada Secretary of State after the reverse split ratio is finalized.
YIJIA GROUP CORP. (YJGJ) Q1 Highlights The filing shows total revenue of $108,477 for the period, producing reported gross profit amounts of $68,781 and $73,173 in comparative periods. The company recorded a loss before income tax of $32,440 (and a prior period loss of $45,414). Share capital outstanding totaled 25,012,270 shares. Management applied a full valuation allowance against deferred tax assets, with a net change in that allowance of $17,397. The company reports significant customer and vendor concentrations: one customer ("Customer B") accounted for 100% of revenues amounting to $108,477 and a single vendor represented 54% of purchases ($114,598). Cash balances include material uninsured amounts of $468,926 and $301,267. The company issued share-based compensation arrangements (60,000 shares to the CFO at $0.05 fair value) with common stock issuable of $3,000. Financial statements are unaudited and certain schedules (allowances for credit losses and obsolete inventory) show no recorded reserves.